跳至主要内容
临床试验/NCT00827931
NCT00827931已完成4 期

Prospective Randomized Phase IV Open Label Comparative Study Of Tranexamic Acid Plus Standard Of Care Vs Standard Of Care For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery

Pfizer1 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2009年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Pfizer
入组人数
94
试验地点
1
主要终点
Post-operative Blood Loss

研究概览

简要总结

Tranexamic acid has been shown to reduce postoperative blood losses and transfusion requirements in various types of major surgery (orthopedic surgery, spine surgery, cardiopulmonary bypass, liver resections, and gynecological cancers).The current trial is being conducted to compare the efficacy of tranexamic acid plus standard of care versus standard of care in reduction of blood loss in patients undergoing major abdominal surgeries.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient undergoing major abdominal surgery (Biliary strictures, Pancreatico-duodenectomy, Esophagectomy, Total proctocolectomy, Hemicolectomy, Gastrectomy, Other major abdominal surgeries with similar expected blood loss)

排除标准

  • Patients with a platelet count less than 100, 000/mm3 or history of thrombocytopenia.
  • Patients with known coagulopathy.
  • Patients with anemia (hemoglobin levels less than 8 mg/dl)
  • Patients with documented DVT or PE at screening or in past three months.
  • Patients with any associated major illness (e.g., severe cardiac or respiratory disease).
  • Anticoagulants (other than LMWH or heparin in prophylactic doses to prevent deep vein thrombosis), direct thrombin inhibitors or thrombolytic therapy administered or completed within last week

研究组 & 干预措施

A

Experimental

end of the operation and on the mornings of the first, second, fourth and seventh postoperative days.

干预措施: Tranexamic acid + Standard of Care (Drug)

B

Other

Standard of Care

干预措施: Standard of Care (Procedure)

结局指标

主要结局

Post-operative Blood Loss

时间窗: Post-operation, Day 1, Day 2 up to drain removal

Post-operative blood loss was defined as the sum of the drainage volumes measured over post-operative days 1, 2, and at drain removal. It was measured by weighing the drapes/ dressings or swabs prior to soaking to measure difference in weight and checking drain collectors until drains were removed.

次要结局

  • Intra-operative Blood Loss(Day 1 (End of surgery))
  • Total Blood Loss(Baseline through Day 2 post-surgery)
  • Total Blood Loss as Assessed by the Gross' Formula(Baseline through Day 2 post-surgery)
  • Percentage of Participants Receiving Transfusions(Up to Day 7 post-surgery)
  • Hemoglobin Levels(End of surgery, Day 1, Day 2, Day 4 and Day 7/End of treatment (EoT) post-surgery)
  • Number of Participants With Deep Vein Thrombosis (DVT) Post Surgery(Day 7 post-surgery)

研究者

发起方
Pfizer
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验